Peer Review History

Original SubmissionJune 18, 2020
Decision Letter - Michael Knapp, Editor

PONE-D-20-18736

Relationships between fox populations and rabies virus spread in northern Canada

PLOS ONE

Dear Dr. Nadin-Davis,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Both reviewers agree that the manuscript is of interest, but require a number of clarifications. Reviewer 2 in particular has asked for more details on the analyses to better evaluate the results. Please address all reviewer comments prior to re-submission.

Please submit your revised manuscript by Dec 07 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Michael Knapp

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you are reporting an analysis of a microarray, next-generation sequencing, or deep sequencing data set. PLOS requires that authors comply with field-specific standards for preparation, recording, and deposition of data in repositories appropriate to their field. Please upload these data to a stable, public repository (such as ArrayExpress, Gene Expression Omnibus (GEO), DNA Data Bank of Japan (DDBJ), NCBI GenBank, NCBI Sequence Read Archive, or EMBL Nucleotide Sequence Database (ENA)). In your revised cover letter, please provide the relevant accession numbers that may be used to access these data. For a full list of recommended repositories, see http://journals.plos.org/plosone/s/data-availability#loc-omics or http://journals.plos.org/plosone/s/data-availability#loc-sequencing

3. We note that [Figures 1, 4 and S1] in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

1.     You may seek permission from the original copyright holder of Figures [1, 4 and S1] to publish the content specifically under the CC BY 4.0 license. 

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

2.     If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/ 

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This manuscript provides new data and analysis on rabies virus and host genetics in the Canadian North

The paper is very well written and the experiments and analysis are very well described and appropriate to address the question of rabies spread and maintenance in the Canadian North. Conclusions are well supported by the data presented. The findings and discussion contribute to our understanding of rabies dynamics is the far North, and analyses virus spread into more southern regions.

I only have a view minor comments:

Line 89: should this be last century instead of earlier this century? How much has fox farming decreased in the last 20 years vs 50 or 100- years?

Line 701: sentence needs to be corrected

Line 708: Should this be group A3- 4 instead of group 4?

Reviewer #2: This is an interesting study and an impressive amount of work and sampling considering the remote locations being studied. However, I think the presentation could be improved. In particular, more details are needed in the methods, and some of the most interesting findings are presented in text only and are not visible on the figures.

Major comments:

Most of the conclusions about how rabies spreads within and between hosts cannot currently be verified, because host information is missing from key figures. Please annotate the time-scaled phylogeny and the maps with at least the major hosts (e.g. arctic fox, red fox, other).

Line 119: More detail about temporal differences in surveillance is needed, as the data covers a very long time period. I was left wondering for how much of this period non-contact animals had been tested, and how such samples were treated before the DRIT became available. I was under the impression that the DRIT is a relatively recent development?

Line 148-150: More details needed here:

1. Which alignment algorithm was used?

2. Which substitution models were used for these analyses?

3. Three distinct phylogenetic methods are discussed, but the maximum likelihood results are never presented. I don’t think all three are necessarily needed, but arguably the maximum likelihood phylogeny would be more robust than the neighbour joining analysis presented, if both are available.

Line 162: Which phylogeny was used in these analyses? The preceding text describes multiple phylogenetic reconstructions, and here a new alignment is introduced. Since nothing is specified I’d assume the authors relied on automatic reconstructions of phylogeny by HyPhy/datamonkey, but if so this needs to be specified, ideally along with the substitution model used in these instances. Using the same phylogeny as presented elsewhere would be better, but otherwise at least a statement confirming that the topology didn’t differ from what is shown is needed.

Line 237: Which diversity measures were used? A very large number of measures exists (e.g. Shannon, Simpson, etc.), and a quick look at the Arlequin documentation suggests it can calculate several (though the documentation does not specify which).

Line 269: Clade A1 is not strongly supported – the node grouping all A1 sequences has just 51% bootstrap support, and no value is shown for the split between A1 and all other clades.

Line 282: The methods did not contain information about how the outgroup was chosen. Also, more information should be given here:

1. Please annotate major hosts (as discussed above)

2. Which of the tips represent sequences generated in this study?

3. Do clusters correspond to anything (e.g. broad locations)?

Line 319: As above, this figure should show hosts, and here knowing the hosts becomes central to the arguments of the paper.

Line 324: “posterior value” is vague – presumably this should be “posterior probability”?

Line 327: Can the cases with no precise coordinates be illustrated another way, e.g. by writing the number of cases in the centre of Alaska, with the font coloured the same as the group? At present it’s unclear from the maps and other figures where Alaskan samples fit in and whether they are all a single phylogenetic group.

Line 350: Point shapes should reflect sampled host. Potential changes in host as the virus spreads are discussed in the text, so it would be nice to be able to see this and to get a sense of how many cases are being used to support such statements.

Line 373: When giving estimated dates of MRCAs, please include some measure of confidence, such as a 95% credible interval / HPD.

Line 615-618: I could not follow this argument – how can the suggested limited level differentiation be supported by findings of significant differentiation? The following sentence goes on to say that others have found North/South differentiation.

Minor comments:

Line 35-38: It took me a while to understand this sentence and that it is the species which differ, and not the data types giving conflicting results. This might be clearer with an added “both”, as in: “…, but both mitochondrial DNA control region sequences and 9-locus microsatellite genotypes revealed…”

Line 55: Technically this should read “Rabies lyssavirus (RABV)…”, as the sentence is referring to the species.

Line 134: The acronym “AFX” is used throughout the manuscript, but has not been defined as far as I can tell. Since only one variant is being discussed and there are many other acronyms to remember, is this one needed?

Line 194: In figure 1, it is very hard to distinguish the small circles from small squares used to plot “other” locations.

Line 199: Potential typo: should this be “hamstermap.com”?

Line 283: The methods said version 7 of MEGA was used.

Line 372: Unclear why the numbering scheme changes for these lineages, both here and in the plot. Earlier A3 sub-lineages were simply referred to by number.

Line 511: Is this line meant to refer to table S5 instead?

Line 589-590: I found the final part of this sentence confusing, since no results contrasting the rabies and host population genetics results had been presented by this point. Perhaps write: “allowing us correlate…” or “this allows us to correlate”, to indicate that this is still coming in the next paragraphs.

Line 736: Is the word “detection” missing here?

Supplementary document:

1. Caption for table S3 is incomplete, with placeholder text where the authors intended to add accession numbers.

2. Caption for table S4 refers to a “Table d1”, which is presumably a typo.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Karsten Hueffer

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Please see the response to reviewers file.

Attachments
Attachment
Submitted filename: Respone to reviewers.docx
Decision Letter - Michael Knapp, Editor

Relationships between fox populations and rabies virus spread in northern Canada

PONE-D-20-18736R1

Dear Dr. Nadin-Davis,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Michael Knapp

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Michael Knapp, Editor

PONE-D-20-18736R1

Relationships between fox populations and rabies virus spread in northern Canada

Dear Dr. Nadin-Davis:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Michael Knapp

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .